Genmab A/S (GMAB)
Genmab Market Cap : 15.86B for March 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novo Nordisk A/S | 164.61B |
| AbbVie, Inc. | 364.62B |
| Krystal Biotech, Inc. | 7.546B |
| Ascendis Pharma A/S | 13.73B |
| Zealand Pharma A/S | 2.894B |
Market Cap Related Metrics
| PE Ratio | 16.63 |
| PS Ratio | 4.398 |
| Price to Book Value | 2.712 |
| Price to Free Cash Flow | 14.45 |
| Price | 25.74 |
| Earnings Yield | 6.01% |
| Operating PE Ratio | 13.09 |
| Normalized PE Ratio | 14.79 |